Processa Pharmaceuticals PCSA
NASDAQ PCSA
$1.88 +0.01 (+0.28%)
As of: Nov 11, 2026 · 9:48 AM EST

Processa Pharmaceuticals (PCSA) Liabilities from Discontinued Operations (2014 - 2016)

Updated

Processa Pharmaceuticals (PCSA) reported Liabilities from Discontinued Operations of $307,219 for Q1 2016, up 2.3% from the prior quarter.

Analysis

Processa Pharmaceuticals (PCSA) Liabilities from Discontinued Operations (2014 - 2016) Analysis & Trends

At the end of FY2015, Processa Pharmaceuticals posted Liabilities from Discontinued Operations of $300,338, down 33.7% from FY2014.

  • By year, Liabilities from Discontinued Operations came in at $453,193 in FY2014.
  • The Q1 2016 figure ranks as the highest quarterly Liabilities from Discontinued Operations since Q4 2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Processa Pharmaceuticals 5.22 Mn -8.52 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2016 307,219.00
Dec 31, 2015 300,338.00
Sep 30, 2015 43,549.00
Dec 31, 2014 453,193.00
API Access

Processa Pharmaceuticals Liabilities from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=PCSA&period=max&api_key=YOUR_API_KEY